Gene:
KRT12
keratin 12

PharmGKB contains no dosing guidelines for this . To report known genotype-based dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB has no annotated drug labels with pharmacogenomic information for this . If you know of a drug label with PGx, send us a message.

PharmGKB contains no Clinical Variants that meet the highest level of criteria.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

Overview

Alternate Names:  Meesmann corneal dystrophy
Alternate Symbols:  K12
PharmGKB Accession Id: PA30201

Details

Cytogenetic Location: chr17 : q12 - q21.2
GP mRNA Boundary: chr17 : 39017430 - 39023462
GP Gene Boundary: chr17 : 39014430 - 39033462
Strand: minus

Visualization

UCSC has a Genome Browser that you can use to view PharmGKB annotations for this gene in context with many other sources of information.

View on UCSC Browser
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

LinkOuts

Entrez Gene:
3859
OMIM:
122100
601687
UCSC Genome Browser:
NM_000223
RefSeq RNA:
NM_000223
RefSeq Protein:
NP_000214
RefSeq DNA:
AC_000060
AC_000149
NC_000017
NG_008077
NT_010783
NW_001838435
NW_926828
UniProtKB:
K1C12_HUMAN (Q99456)
Ensembl:
ENSG00000187242
GenAtlas:
KRT12
GeneCard:
KRT12
MutDB:
KRT12
ALFRED:
LO011206K
HuGE:
KRT12
Comparative Toxicogenomics Database:
3859
ModBase:
Q99456
HumanCyc Gene:
HS03075
HGNC:
6414

Common Searches